Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Abstract Unlike many other solid tumors, high-grade serous ovarian cancer seldom spreads outside the abdominal cavity. The most common cause of death is malnutrition secondary to intestinal obstruction because of abdominal metastasis. Understanding the key mechanisms involved in driving abdominal metastases is important for the development of novel strategies to prevent metastasis. In this talk, I will present our recent work on preventing ovarian cancer metastasis by targeting Salt Inducible Kinase 2 (SIK2). Citation Format: Ahmed Ashour Ahmed. Targeting micrometastasis for the treatment of ovarian cancer. [abstract]. In: Proceedings of the AACR Conference: Addressing Critical Questions in Ovarian Cancer Research and Treatment; Oct 1-4, 2017; Pittsburgh, PA. Philadelphia (PA): AACR; Clin Cancer Res 2018;24(15_Suppl):Abstract nr IA07.

Original publication

DOI

10.1158/1557-3265.ovca17-ia07

Type

Conference paper

Publisher

American Association for Cancer Research (AACR)

Publication Date

01/08/2018

Volume

24

Pages

IA07 - IA07